Suven Life Sciences Ltd Half Yearly Results

Gross Sales

3.58

4.84

6.86

5.61

7.93

Excise Duty

0

0

0

0

0

Net Sales

3.58

4.84

6.86

5.61

7.93

Other Operating Income

0

0

0

0

0

Other Income

8.04

10.35

18.24

7.81

6.64

Total Income

11.62

15.18

25.09

13.42

14.57

Total Expenditure

86.33

81.32

58.38

88.72

50.7

PBIDT

-74.7

-66.13

-33.29

-75.3

-36.14

Interest

0.04

0.07

0.09

0.12

0.17

PBDT

-74.74

-66.2

-33.38

-75.42

-36.31

Depreciation

2.94

3.11

3.39

3.34

3.2

Minority Interest Before NP

0

0

0

0

0

Tax

0

-1

0

0

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-77.68

-68.31

-36.77

-78.76

-39.51

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-77.68

-68.31

-36.77

-78.76

-39.51

Extra-ordinary Items

0

0

7.46

0

6

Adjusted Profit After Extra-ordinary item

-77.68

-68.31

-44.23

-78.76

-45.51

EPS (Unit Curr.)

-3.56

0

-1.69

0

-2.72

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

21.81

21.81

21.81

21.81

12.73

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-2,086.59

-1,366.32

-485.27

-1,342.24

-455.73

PBDTM(%)

-

-

-

-

-

PATM(%)

-2,169.83

-1,411.36

-536

-1,403.92

-498.23